(19)
(11) EP 3 350 226 A2

(12)

(88) Date of publication A3:
04.05.2017

(43) Date of publication:
25.07.2018 Bulletin 2018/30

(21) Application number: 16770571.4

(22) Date of filing: 16.09.2016
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
(86) International application number:
PCT/IB2016/055559
(87) International publication number:
WO 2017/046776 (23.03.2017 Gazette 2017/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 16.09.2015 US 201562219599 P

(71) Applicant: Prothena Biosciences Limited
Co. Dublin A96 T927 (IE)

(72) Inventors:
  • LIU, Yue
    Foster City, California 94404 (US)
  • GARIDEL, Patrick
    55216 Ingelheim Am Rhein (DE)
  • LANGER, Andreas
    55216 Ingelheim am Rhein (DE)
  • FLANAGAN, Kenneth
    Alameda, CA 94501 (US)

(74) Representative: Truscott, Glyn John 
Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus
London EC1N 2HA
London EC1N 2HA (GB)

   


(54) USE OF ANTI-MCAM ANTIBODIES FOR TREATMENT OR PROPHYLAXIS OF GIANT CELL ARTERITIS, POLYMYALGIA RHEUMATICA OR TAKAYASU'S ARTERITIS